222 related articles for article (PubMed ID: 7948965)
1. Allogeneic skin grafting for extensive skin chronic graft-versus-host disease.
Kondo S; Tamura K; Makino S; Takamatsu Y
Int J Hematol; 1994 Aug; 60(2):151-5. PubMed ID: 7948965
[TBL] [Abstract][Full Text] [Related]
2. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
Baumeister RG; Riel KA; Kolb HJ
Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient.
Kamei Y; Torii S; Hasegawa M; Toriyama K; Kodera Y
Transplantation; 1993 Dec; 56(6):1530-1. PubMed ID: 8279030
[No Abstract] [Full Text] [Related]
4. Chronic Ulcer by Cutaneous GvHD After Bone Marrow Transplantation Treated With Skin Allograft From HLA-Identical Donor: Case Report and Literature Review.
Amendola F; Gazzola R; Lombardo M; Caminiti R; Dagna L; Baruffaldi-Preis FW
Int J Low Extrem Wounds; 2016 Jun; 15(2):139-41. PubMed ID: 27009789
[TBL] [Abstract][Full Text] [Related]
5. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE
Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018
[TBL] [Abstract][Full Text] [Related]
7. Successful one antigen mismatched bone marrow transplant for chronic myeloid leukemia (CML) after two failed syngeneic transplants.
Manna A; Bacigalupo A; Palazzo G; Amurri B; Maggi A; Mazza P
Bone Marrow Transplant; 1999 May; 23(10):1085-6. PubMed ID: 10373077
[TBL] [Abstract][Full Text] [Related]
8. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Okano A; Shimazaki C; Ochiai N; Hatsuse M; Takahashi R; Ashihara E; Inaba T; Fujita N; Noda Y; Nakagawa M
Bone Marrow Transplant; 2001 Oct; 28(7):709-11. PubMed ID: 11704796
[TBL] [Abstract][Full Text] [Related]
10. Graft-versus-leukemia effect after allogeneic bone marrow transplantation for chronic lymphocytic leukemia.
Rondón G; Giralt S; Huh Y; Khouri I; Andersson B; Andreeff M; Champlin R
Bone Marrow Transplant; 1996 Sep; 18(3):669-72. PubMed ID: 8879640
[TBL] [Abstract][Full Text] [Related]
11. Coronary artery disease following bone marrow transplantation.
Chan KW; Taylor GP; Shepherd JD; Shepherd WE
Bone Marrow Transplant; 1989 May; 4(3):327-30. PubMed ID: 2659118
[TBL] [Abstract][Full Text] [Related]
12. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic donor split skin grafts for treatment of refractory ulcers in cutaneous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation-a retrospective analysis on seven patients.
Lamby P; Wolff D; Mielke S; Grigoleit GU; Ljungman P; Hilgendorf I; Holler E; Holler B; Weber D; Herr W; Schiltz D; Klein S; Graf S; Bjornhagen-Safwenberg V; Dolderer J; Prantl L
Ann Hematol; 2019 Aug; 98(8):1867-1875. PubMed ID: 30993415
[TBL] [Abstract][Full Text] [Related]
14. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
15. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
16. Acute GVHD involving the gastrointestinal tract and infestation with Blastocystis hominis in a patient with chronic myeloid leukaemia following allogeneic bone marrow transplantation.
Ghosh K; Ayyaril M; Nirmala V
Bone Marrow Transplant; 1998 Dec; 22(11):1115-7. PubMed ID: 9877276
[TBL] [Abstract][Full Text] [Related]
17. [Chronic graft-versus-host disease presenting as bullous lesions].
del Pozo J; García-Silva J; Yebra-Pimentel MT
Actas Dermosifiliogr; 2008 Dec; 99(10):803-7. PubMed ID: 19091220
[TBL] [Abstract][Full Text] [Related]
18. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
[TBL] [Abstract][Full Text] [Related]
19. Molecular remission induced by fractionated dose-escalating donor leukocyte infusion without graft-versus-host disease in a patient with chronic myelogenous leukemia relapsed after allogeneic bone marrow transplantation.
Inai K; Wano Y; Yamamoto S; Ikebata Y; Iwasaki H; Tsutani H; Naiki H; Ueda T
Anticancer Res; 1999; 19(6C):5631-4. PubMed ID: 10697631
[TBL] [Abstract][Full Text] [Related]
20. Atypical chronic graft-versus-host disease following interferon therapy for chronic myeloid leukaemia relapsing after allogeneic BMT.
Serrano J; Prieto E; Mazarbeitia F; Román A; Llamas P; Tomás JF
Bone Marrow Transplant; 2001 Jan; 27(1):85-7. PubMed ID: 11244442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
